Medication-releasing lens could treat glaucoma
Contact lenses that release latanoprost are at least as effective as latanoprost drops in reducing intraocular pressure, study finds.
Eye drops to reduce intraocular pressure (IOP) are the first-line treatment for glaucoma, but they are associated with poor adherence because of difficulties with self-administration, as well as stinging and burning sensations.
Researchers at Harvard Medical School in Boston, Massachusetts, developed a drug-eluting lens that can continuously release the prostaglandin analogue latanoprost. They tested it in four monkeys with induced glaucoma over one week.
The team found that wearing the lenses significantly reduced IOP at multiple time points compared with baseline. Both doses tested were at least as effective as latanoprost 0.005% drops in reducing IOP, the researchers report in Ophthalmology (online, 29 August 2016).
The team say that more work will be needed to determine the optimal continual-release dosage but -lens delivery could become a new treatment option for glaucoma.
Citation: Clinical Pharmacist DOI: 10.1211/CP.2016.20201689
Recommended from Pharmaceutical Press
A comprehensive study guide which summarises the basic principles in pharmacy practice. Clear, bulleted information for quick reference.£43.00
A user friendly, single point of reference for healthcare professionals in the safe and effective administration of injectable medicines.£54.00
An essential guide on pharmacovigilance of medicinal products for human use. Practical advice for developing effective pharmacovigilance systems.£38.00
A study aid with 800 MCQs. Assess your knowledge, analytical skills, and ability to apply this knowledge base in clinical practice.£25.00
Reviews over-the-counter medicines, arranged by the conditions they are licensed to treat. Includes product recommendations.£38.00